Motixafortide
id:
motixafortide-180-13749731
title:
Motixafortide
text:
Motixafortide, sold under the brand name Aphexda, is a medication used for the treatment of multiple myeloma. Motixafortide is a hematopoietic stem cell mobilizer and a CXCR4 antagonist. It is given by subcutaneous injection. The most common side effects include injection site reactions, pruritus, flushing, and back pain. Motixafortide was approved for medical use in the United States in September 2023.
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Motixafortide
date created:
2023-09-14T08:30:51Z
date modified:
2024-09-05T13:59:33Z
main entity:
{"identifier":"Q27276305","url":"https://www.wikidata.org/entity/Q27276305"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/8e/Motixafortide.svg","width":1830,"height":1345}
fields total:
13
integrity:
16